In a filing, Pennymac Mortgage Investment Trust revealed its Director Lynch Catherine A. acquired Company’s shares for reported $33932.0 on Sep 22 ’25. In the deal valued at $12.02 per share,2,823 shares were bought. As a result of this transaction, Lynch Catherine A. now holds 54,711 shares worth roughly $0.65 million.
Then, Lynch Catherine A. bought 1,366 shares, generating $16,954 in total proceeds. Upon buying the shares at $12.41, the Director now owns 51,888 shares.
Before that, Lynch Catherine A. bought 2,878 shares. Pennymac Mortgage Investment Trust shares valued at $34,968 were divested by the Director at a price of $12.15 per share. As a result of the transaction, Lynch Catherine A. now holds 49,254 shares, worth roughly $0.58 million.
A number of analysts have revised their coverage, including Keefe Bruyette’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Mkt perform”. Keefe Bruyette also remained covering PMT and has increased its forecast on July 10, 2024 with a “an Outperform” recommendation from previously “Mkt perform” rating. Deutsche Bank started covering the stock on January 10, 2024. It rated PMT as “a Hold”.
Price Performance Review of PMT
On Monday, Pennymac Mortgage Investment Trust [NYSE:PMT] saw its stock jump 0.68% to $11.85. Over the last five days, the stock has lost -4.74%. Pennymac Mortgage Investment Trust shares have fallen nearly -17.48% since the year began. Nevertheless, the stocks have fallen -5.88% over the past one year.
How much short interest is there in Pennymac Mortgage Investment Trust?
A steep rise in short interest was recorded in Pennymac Mortgage Investment Trust stocks on 2025-09-30, dropping by -0.58 million shares to a total of 3.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 4.27 million shares. There was a decline of -15.58%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 06, 2023 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $13.50 price target.
